Bio-Reference Laboratories Inc.'s (BRLI) first-quarter net income decreased to $7.36 million or $0.26 per share from $7.99 million or $0.28 per share last year.
The company recorded quarterly revenues of $149.92 million, a 23% increase over $121.66 million reported in the prior-year quarter.
On average, 5 analysts polled by Thomson Reuters expected earnings per share of $0.21 on $143.13 million revenue for the quarter. Analysts' estimates typically exclude one-time items.
Marc Grodman, MD, CEO, commented: "The milder than normal weather conditions, particularly in the Northeast, have contributed to the strength of our Q1 results when compared to our prior year results. However, and more importantly, the overall success of all our business units has been the primary reason for our strong financial results."
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org